chr18-32204234-G-T

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_005925.3(MEP1B):​c.421G>T​(p.Gly141Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MEP1B
NM_005925.3 missense

Scores

12
6
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.95
Variant links:
Genes affected
MEP1B (HGNC:7020): (meprin A subunit beta) Meprins are multidomain zinc metalloproteases that are highly expressed in mammalian kidney and intestinal brush border membranes, and in leukocytes and certain cancer cells. They are involved in the hydrolysis of a variety of peptide and protein substrates, and have been implicated in cancer and intestinal inflammation. Mature meprins are oligomers of evolutionarily related, but separately encoded alpha and/or beta subunits. Homooligomers of alpha subunit are secreted, whereas, oligomers containing the beta subunit are plasma membrane-bound. This gene encodes the beta subunit. Targeted disruption of this gene in mice affects embryonic viability, renal gene expression profiles, and distribution of the membrane-associated alpha subunit in kidney and intestine. [provided by RefSeq, Oct 2011]
GAREM1 (HGNC:26136): (GRB2 associated regulator of MAPK1 subtype 1) This gene encodes an adaptor protein which functions in the epidermal growth factor (EGF) receptor-mediated signaling pathway. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.983

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MEP1BNM_005925.3 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/15 ENST00000269202.11 NP_005916.2
MEP1BNM_001308171.2 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/15 NP_001295100.1
MEP1BXM_011526013.3 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/14 XP_011524315.1
MEP1BXM_011526014.3 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/13 XP_011524316.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MEP1BENST00000269202.11 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/151 NM_005925.3 ENSP00000269202 P4
MEP1BENST00000581447.1 linkuse as main transcriptc.421G>T p.Gly141Trp missense_variant 7/151 ENSP00000463280 A1
GAREM1ENST00000583696.1 linkuse as main transcriptc.66-67774C>A intron_variant 3 ENSP00000464185
MEP1BENST00000581184.5 linkuse as main transcriptn.466G>T non_coding_transcript_exon_variant 7/73

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1454044
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
722284
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 13, 2022The c.421G>T (p.G141W) alteration is located in exon 7 (coding exon 7) of the MEP1B gene. This alteration results from a G to T substitution at nucleotide position 421, causing the glycine (G) at amino acid position 141 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.78
D;D;D
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Pathogenic
0.98
D;D;D
MetaSVM
Uncertain
0.46
D
MutationAssessor
Pathogenic
4.4
.;H;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-8.0
.;D;.
REVEL
Pathogenic
0.79
Sift
Pathogenic
0.0
.;D;.
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
.;D;.
Vest4
0.93, 0.91
MutPred
0.84
.;Loss of disorder (P = 0.0311);Loss of disorder (P = 0.0311);
MVP
0.87
MPC
0.58
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.91
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr18-29784197; API